Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H40Cl2N6O8S |
InChIKeyQPKXJIBPFUZACW-RRAHZORUSA-N |
CAS Registry2222635-85-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | US | 22 Jan 2018 | |
Leukemia | Preclinical | US | 22 Jan 2018 |